nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—PTGS2—kidney cancer	0.317	1	CbGaD
Tetrahydrobiopterin—NOS3—Doxorubicin—kidney cancer	0.292	1	CbGbCtD
Tetrahydrobiopterin—NOS3—nephron—kidney cancer	0.0135	0.338	CbGeAlD
Tetrahydrobiopterin—PAH—renal system—kidney cancer	0.00485	0.121	CbGeAlD
Tetrahydrobiopterin—PAH—kidney—kidney cancer	0.00469	0.117	CbGeAlD
Tetrahydrobiopterin—PTGS2—nephron—kidney cancer	0.00428	0.107	CbGeAlD
Tetrahydrobiopterin—TH—renal system—kidney cancer	0.00294	0.0736	CbGeAlD
Tetrahydrobiopterin—TH—kidney—kidney cancer	0.00285	0.0712	CbGeAlD
Tetrahydrobiopterin—NOS3—renal system—kidney cancer	0.00265	0.0663	CbGeAlD
Tetrahydrobiopterin—NOS3—kidney—kidney cancer	0.00256	0.0641	CbGeAlD
Tetrahydrobiopterin—PTGS2—renal system—kidney cancer	0.000839	0.021	CbGeAlD
Tetrahydrobiopterin—PTGS2—kidney—kidney cancer	0.000811	0.0203	CbGeAlD
Tetrahydrobiopterin—Skin disorder—Everolimus—kidney cancer	0.000388	0.00224	CcSEcCtD
Tetrahydrobiopterin—Infection—Erlotinib—kidney cancer	0.000383	0.00221	CcSEcCtD
Tetrahydrobiopterin—Cardiovascular disorder—Doxorubicin—kidney cancer	0.000379	0.00219	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Erlotinib—kidney cancer	0.000378	0.00218	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Erlotinib—kidney cancer	0.000375	0.00216	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Capecitabine—kidney cancer	0.000375	0.00216	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Gemcitabine—kidney cancer	0.000374	0.00216	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Gemcitabine—kidney cancer	0.000372	0.00215	CcSEcCtD
Tetrahydrobiopterin—Cough—Sorafenib—kidney cancer	0.000371	0.00214	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Paclitaxel—kidney cancer	0.000369	0.00213	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Temsirolimus—kidney cancer	0.000368	0.00212	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000367	0.00212	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000364	0.0021	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Sorafenib—kidney cancer	0.000362	0.00209	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.00036	0.00208	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Vincristine—kidney cancer	0.000358	0.00207	CcSEcCtD
Tetrahydrobiopterin—Irritability—Capecitabine—kidney cancer	0.000358	0.00206	CcSEcCtD
Tetrahydrobiopterin—Cough—Sunitinib—kidney cancer	0.000357	0.00206	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Temsirolimus—kidney cancer	0.000356	0.00205	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Sunitinib—kidney cancer	0.000355	0.00205	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Everolimus—kidney cancer	0.000352	0.00203	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Paclitaxel—kidney cancer	0.000352	0.00203	CcSEcCtD
Tetrahydrobiopterin—Infestation—Paclitaxel—kidney cancer	0.000352	0.00203	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000352	0.00203	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Sunitinib—kidney cancer	0.000348	0.00201	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Sorafenib—kidney cancer	0.000347	0.002	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Paclitaxel—kidney cancer	0.000347	0.002	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Pazopanib—kidney cancer	0.000347	0.002	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000346	0.002	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Everolimus—kidney cancer	0.000345	0.00199	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Paclitaxel—kidney cancer	0.000345	0.00199	CcSEcCtD
Tetrahydrobiopterin—Infection—Sorafenib—kidney cancer	0.000345	0.00199	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Capecitabine—kidney cancer	0.000342	0.00198	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Paclitaxel—kidney cancer	0.000342	0.00197	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Temsirolimus—kidney cancer	0.000342	0.00197	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Sorafenib—kidney cancer	0.00034	0.00197	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Gemcitabine—kidney cancer	0.00034	0.00196	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Erlotinib—kidney cancer	0.00034	0.00196	CcSEcCtD
Tetrahydrobiopterin—Rash—Temsirolimus—kidney cancer	0.000339	0.00196	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Temsirolimus—kidney cancer	0.000339	0.00196	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Sorafenib—kidney cancer	0.000337	0.00195	CcSEcCtD
Tetrahydrobiopterin—Headache—Temsirolimus—kidney cancer	0.000337	0.00194	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Capecitabine—kidney cancer	0.000335	0.00193	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Pazopanib—kidney cancer	0.000335	0.00193	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000333	0.00192	CcSEcCtD
Tetrahydrobiopterin—Infection—Sunitinib—kidney cancer	0.000332	0.00192	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Capecitabine—kidney cancer	0.000332	0.00191	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Vinblastine—kidney cancer	0.000328	0.0019	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Sunitinib—kidney cancer	0.000328	0.00189	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Everolimus—kidney cancer	0.000327	0.00189	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Sunitinib—kidney cancer	0.000324	0.00187	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Pazopanib—kidney cancer	0.000322	0.00186	CcSEcCtD
Tetrahydrobiopterin—Rash—Pazopanib—kidney cancer	0.000319	0.00184	CcSEcCtD
Tetrahydrobiopterin—Nausea—Temsirolimus—kidney cancer	0.000319	0.00184	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Pazopanib—kidney cancer	0.000319	0.00184	CcSEcCtD
Tetrahydrobiopterin—Agitation—Vincristine—kidney cancer	0.000318	0.00184	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Vinblastine—kidney cancer	0.000317	0.00183	CcSEcCtD
Tetrahydrobiopterin—Headache—Pazopanib—kidney cancer	0.000317	0.00183	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000316	0.00183	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Everolimus—kidney cancer	0.000316	0.00182	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Everolimus—kidney cancer	0.000316	0.00182	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Erlotinib—kidney cancer	0.000316	0.00182	CcSEcCtD
Tetrahydrobiopterin—Infection—Dactinomycin—kidney cancer	0.000314	0.00181	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Paclitaxel—kidney cancer	0.000314	0.00181	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Paclitaxel—kidney cancer	0.000311	0.0018	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Sorafenib—kidney cancer	0.000306	0.00176	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Erlotinib—kidney cancer	0.000305	0.00176	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Erlotinib—kidney cancer	0.000305	0.00176	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000304	0.00176	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Capecitabine—kidney cancer	0.000303	0.00175	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000301	0.00174	CcSEcCtD
Tetrahydrobiopterin—Nausea—Pazopanib—kidney cancer	0.000301	0.00174	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Vincristine—kidney cancer	0.0003	0.00173	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.0003	0.00173	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Vinblastine—kidney cancer	0.000296	0.00171	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Everolimus—kidney cancer	0.000295	0.0017	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Sunitinib—kidney cancer	0.000294	0.0017	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Capecitabine—kidney cancer	0.000289	0.00167	CcSEcCtD
Tetrahydrobiopterin—Infestation—Capecitabine—kidney cancer	0.000289	0.00167	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000288	0.00166	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000288	0.00166	CcSEcCtD
Tetrahydrobiopterin—Cough—Gemcitabine—kidney cancer	0.000287	0.00165	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Paclitaxel—kidney cancer	0.000285	0.00164	CcSEcCtD
Tetrahydrobiopterin—Acute coronary syndrome—Capecitabine—kidney cancer	0.000285	0.00164	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000284	0.00164	CcSEcCtD
Tetrahydrobiopterin—Myocardial infarction—Capecitabine—kidney cancer	0.000283	0.00163	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Vincristine—kidney cancer	0.000283	0.00163	CcSEcCtD
Tetrahydrobiopterin—Infection—Vincristine—kidney cancer	0.000281	0.00162	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Capecitabine—kidney cancer	0.000281	0.00162	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Gemcitabine—kidney cancer	0.00028	0.00161	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000278	0.0016	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Vincristine—kidney cancer	0.000277	0.0016	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Paclitaxel—kidney cancer	0.000275	0.00159	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vinblastine—kidney cancer	0.000275	0.00159	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Sorafenib—kidney cancer	0.000274	0.00158	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Sorafenib—kidney cancer	0.000274	0.00158	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Everolimus—kidney cancer	0.000274	0.00158	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000273	0.00158	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Gemcitabine—kidney cancer	0.000268	0.00155	CcSEcCtD
Tetrahydrobiopterin—Infection—Gemcitabine—kidney cancer	0.000266	0.00154	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Vinblastine—kidney cancer	0.000266	0.00153	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Everolimus—kidney cancer	0.000264	0.00153	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Sunitinib—kidney cancer	0.000264	0.00152	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Sunitinib—kidney cancer	0.000264	0.00152	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Erlotinib—kidney cancer	0.000264	0.00152	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Gemcitabine—kidney cancer	0.000263	0.00152	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Gemcitabine—kidney cancer	0.00026	0.0015	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000259	0.00149	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000257	0.00149	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Capecitabine—kidney cancer	0.000257	0.00149	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Sorafenib—kidney cancer	0.000256	0.00148	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Capecitabine—kidney cancer	0.000255	0.00147	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Vinblastine—kidney cancer	0.000255	0.00147	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Erlotinib—kidney cancer	0.000255	0.00147	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Everolimus—kidney cancer	0.000254	0.00147	CcSEcCtD
Tetrahydrobiopterin—Agitation—Paclitaxel—kidney cancer	0.000253	0.00146	CcSEcCtD
Tetrahydrobiopterin—Rash—Everolimus—kidney cancer	0.000252	0.00146	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Everolimus—kidney cancer	0.000252	0.00145	CcSEcCtD
Tetrahydrobiopterin—Headache—Vinblastine—kidney cancer	0.000252	0.00145	CcSEcCtD
Tetrahydrobiopterin—Headache—Everolimus—kidney cancer	0.000251	0.00145	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Dactinomycin—kidney cancer	0.00025	0.00144	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Dactinomycin—kidney cancer	0.00025	0.00144	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Sunitinib—kidney cancer	0.000246	0.00142	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Erlotinib—kidney cancer	0.000245	0.00142	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000244	0.00141	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000244	0.00141	CcSEcCtD
Tetrahydrobiopterin—Rash—Erlotinib—kidney cancer	0.000243	0.0014	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Erlotinib—kidney cancer	0.000243	0.0014	CcSEcCtD
Tetrahydrobiopterin—Headache—Erlotinib—kidney cancer	0.000242	0.0014	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000242	0.00139	CcSEcCtD
Tetrahydrobiopterin—Cough—Paclitaxel—kidney cancer	0.00024	0.00139	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vinblastine—kidney cancer	0.000238	0.00138	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Paclitaxel—kidney cancer	0.000238	0.00138	CcSEcCtD
Tetrahydrobiopterin—Nausea—Everolimus—kidney cancer	0.000238	0.00137	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Sorafenib—kidney cancer	0.000238	0.00137	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Paclitaxel—kidney cancer	0.000234	0.00135	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Capecitabine—kidney cancer	0.000234	0.00135	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Dactinomycin—kidney cancer	0.000233	0.00134	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000233	0.00134	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000231	0.00134	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Vincristine—kidney cancer	0.000231	0.00133	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Sorafenib—kidney cancer	0.00023	0.00133	CcSEcCtD
Tetrahydrobiopterin—Nausea—Erlotinib—kidney cancer	0.000229	0.00132	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Sunitinib—kidney cancer	0.000229	0.00132	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Capecitabine—kidney cancer	0.000226	0.0013	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000224	0.0013	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Vincristine—kidney cancer	0.000223	0.00129	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Vincristine—kidney cancer	0.000223	0.00129	CcSEcCtD
Tetrahydrobiopterin—Infection—Paclitaxel—kidney cancer	0.000223	0.00129	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Sunitinib—kidney cancer	0.000221	0.00128	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Sorafenib—kidney cancer	0.000221	0.00127	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain upper—Doxorubicin—kidney cancer	0.000221	0.00127	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Paclitaxel—kidney cancer	0.00022	0.00127	CcSEcCtD
Tetrahydrobiopterin—Rash—Sorafenib—kidney cancer	0.000219	0.00126	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Sorafenib—kidney cancer	0.000219	0.00126	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Paclitaxel—kidney cancer	0.000218	0.00126	CcSEcCtD
Tetrahydrobiopterin—Headache—Sorafenib—kidney cancer	0.000217	0.00126	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Dactinomycin—kidney cancer	0.000216	0.00125	CcSEcCtD
Tetrahydrobiopterin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000216	0.00125	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Doxorubicin—kidney cancer	0.000214	0.00123	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Sunitinib—kidney cancer	0.000212	0.00123	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Gemcitabine—kidney cancer	0.000212	0.00122	CcSEcCtD
Tetrahydrobiopterin—Rash—Sunitinib—kidney cancer	0.000211	0.00122	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Sunitinib—kidney cancer	0.00021	0.00121	CcSEcCtD
Tetrahydrobiopterin—Headache—Sunitinib—kidney cancer	0.000209	0.00121	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Vincristine—kidney cancer	0.000208	0.0012	CcSEcCtD
Tetrahydrobiopterin—Nausea—Sorafenib—kidney cancer	0.000206	0.00119	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000204	0.00118	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Dactinomycin—kidney cancer	0.000201	0.00116	CcSEcCtD
Tetrahydrobiopterin—Rash—Dactinomycin—kidney cancer	0.000199	0.00115	CcSEcCtD
Tetrahydrobiopterin—Nausea—Sunitinib—kidney cancer	0.000198	0.00115	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Paclitaxel—kidney cancer	0.000198	0.00114	CcSEcCtD
Tetrahydrobiopterin—Cough—Capecitabine—kidney cancer	0.000197	0.00114	CcSEcCtD
Tetrahydrobiopterin—Neutropenia—Doxorubicin—kidney cancer	0.000195	0.00113	CcSEcCtD
Tetrahydrobiopterin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000194	0.00112	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000194	0.00112	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Vincristine—kidney cancer	0.000193	0.00112	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Capecitabine—kidney cancer	0.000192	0.00111	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000191	0.0011	CcSEcCtD
Tetrahydrobiopterin—Nausea—Dactinomycin—kidney cancer	0.000188	0.00108	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Vincristine—kidney cancer	0.000187	0.00108	CcSEcCtD
Tetrahydrobiopterin—Infestation—Doxorubicin—kidney cancer	0.000186	0.00107	CcSEcCtD
Tetrahydrobiopterin—Infestation NOS—Doxorubicin—kidney cancer	0.000186	0.00107	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000184	0.00106	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Gemcitabine—kidney cancer	0.000183	0.00106	CcSEcCtD
Tetrahydrobiopterin—Infection—Capecitabine—kidney cancer	0.000183	0.00106	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Doxorubicin—kidney cancer	0.000181	0.00104	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Capecitabine—kidney cancer	0.000181	0.00104	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Vincristine—kidney cancer	0.00018	0.00104	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Capecitabine—kidney cancer	0.000179	0.00103	CcSEcCtD
Tetrahydrobiopterin—Rash—Vincristine—kidney cancer	0.000178	0.00103	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Vincristine—kidney cancer	0.000178	0.00103	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Paclitaxel—kidney cancer	0.000177	0.00102	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Paclitaxel—kidney cancer	0.000177	0.00102	CcSEcCtD
Tetrahydrobiopterin—Headache—Vincristine—kidney cancer	0.000177	0.00102	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Gemcitabine—kidney cancer	0.00017	0.000984	CcSEcCtD
Tetrahydrobiopterin—Rash—Gemcitabine—kidney cancer	0.000169	0.000976	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Gemcitabine—kidney cancer	0.000169	0.000975	CcSEcCtD
Tetrahydrobiopterin—Headache—Gemcitabine—kidney cancer	0.000168	0.000969	CcSEcCtD
Tetrahydrobiopterin—Nausea—Vincristine—kidney cancer	0.000168	0.000969	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000168	0.000969	CcSEcCtD
Tetrahydrobiopterin—Pharyngitis—Doxorubicin—kidney cancer	0.000166	0.000957	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Paclitaxel—kidney cancer	0.000165	0.000954	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Doxorubicin—kidney cancer	0.000165	0.00095	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Capecitabine—kidney cancer	0.000162	0.000936	CcSEcCtD
Tetrahydrobiopterin—Nausea—Gemcitabine—kidney cancer	0.000159	0.000919	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000159	0.000918	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Paclitaxel—kidney cancer	0.000154	0.000886	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000151	0.000869	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Doxorubicin—kidney cancer	0.000151	0.000869	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Paclitaxel—kidney cancer	0.000148	0.000857	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Capecitabine—kidney cancer	0.000146	0.00084	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Capecitabine—kidney cancer	0.000146	0.00084	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Doxorubicin—kidney cancer	0.000145	0.00084	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Paclitaxel—kidney cancer	0.000143	0.000824	CcSEcCtD
Tetrahydrobiopterin—Rash—Paclitaxel—kidney cancer	0.000142	0.000817	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Paclitaxel—kidney cancer	0.000141	0.000816	CcSEcCtD
Tetrahydrobiopterin—Headache—Paclitaxel—kidney cancer	0.000141	0.000812	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Capecitabine—kidney cancer	0.000136	0.000783	CcSEcCtD
Tetrahydrobiopterin—Agitation—Doxorubicin—kidney cancer	0.000134	0.000772	CcSEcCtD
Tetrahydrobiopterin—Nausea—Paclitaxel—kidney cancer	0.000133	0.000769	CcSEcCtD
Tetrahydrobiopterin—Cough—Doxorubicin—kidney cancer	0.000127	0.000733	CcSEcCtD
Tetrahydrobiopterin—Convulsion—Doxorubicin—kidney cancer	0.000126	0.000727	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Capecitabine—kidney cancer	0.000126	0.000727	CcSEcCtD
Tetrahydrobiopterin—Arthralgia—Doxorubicin—kidney cancer	0.000124	0.000715	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000123	0.00071	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Capecitabine—kidney cancer	0.000122	0.000703	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000119	0.000685	CcSEcCtD
Tetrahydrobiopterin—Infection—Doxorubicin—kidney cancer	0.000118	0.000681	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Capecitabine—kidney cancer	0.000117	0.000676	CcSEcCtD
Tetrahydrobiopterin—Nervous system disorder—Doxorubicin—kidney cancer	0.000116	0.000672	CcSEcCtD
Tetrahydrobiopterin—Rash—Capecitabine—kidney cancer	0.000116	0.00067	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Capecitabine—kidney cancer	0.000116	0.00067	CcSEcCtD
Tetrahydrobiopterin—Headache—Capecitabine—kidney cancer	0.000115	0.000666	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Doxorubicin—kidney cancer	0.000115	0.000666	CcSEcCtD
Tetrahydrobiopterin—Nausea—Capecitabine—kidney cancer	0.000109	0.000631	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000108	0.000624	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Doxorubicin—kidney cancer	0.000105	0.000603	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000102	0.000592	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal pain—Doxorubicin—kidney cancer	9.71e-05	0.00056	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Doxorubicin—kidney cancer	9.39e-05	0.000542	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Doxorubicin—kidney cancer	9.39e-05	0.000542	CcSEcCtD
Tetrahydrobiopterin—Hypersensitivity—Doxorubicin—kidney cancer	8.75e-05	0.000505	CcSEcCtD
Tetrahydrobiopterin—Diarrhoea—Doxorubicin—kidney cancer	8.12e-05	0.000469	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Doxorubicin—kidney cancer	7.85e-05	0.000453	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Doxorubicin—kidney cancer	7.55e-05	0.000436	CcSEcCtD
Tetrahydrobiopterin—Rash—Doxorubicin—kidney cancer	7.49e-05	0.000432	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Doxorubicin—kidney cancer	7.48e-05	0.000432	CcSEcCtD
Tetrahydrobiopterin—Headache—Doxorubicin—kidney cancer	7.44e-05	0.000429	CcSEcCtD
Tetrahydrobiopterin—Nausea—Doxorubicin—kidney cancer	7.05e-05	0.000407	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CER1—kidney cancer	6.17e-05	0.000348	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—MAPK1—kidney cancer	6.12e-05	0.000346	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CD4—kidney cancer	6.02e-05	0.00034	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—SLC2A1—kidney cancer	5.99e-05	0.000338	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CYP1A1—kidney cancer	5.95e-05	0.000336	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—RELA—kidney cancer	5.92e-05	0.000334	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	5.84e-05	0.00033	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	5.79e-05	0.000327	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—KRAS—kidney cancer	5.78e-05	0.000326	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CDKN2B—kidney cancer	5.78e-05	0.000326	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—RPL14—kidney cancer	5.68e-05	0.00032	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CDKN1B—kidney cancer	5.66e-05	0.000319	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	5.66e-05	0.000319	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GSTT1—kidney cancer	5.66e-05	0.000319	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ACHE—kidney cancer	5.66e-05	0.000319	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CA9—kidney cancer	5.44e-05	0.000307	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—CCND1—kidney cancer	5.4e-05	0.000305	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—SCARB1—kidney cancer	5.36e-05	0.000302	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS1—kidney cancer	5.3e-05	0.000299	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—SFRP2—kidney cancer	5.25e-05	0.000296	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PSMD7—kidney cancer	5.2e-05	0.000293	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ITPR2—kidney cancer	5.13e-05	0.00029	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—GSTP1—kidney cancer	4.99e-05	0.000282	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ACY1—kidney cancer	4.98e-05	0.000281	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—BCHE—kidney cancer	4.93e-05	0.000278	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—SLC5A5—kidney cancer	4.87e-05	0.000275	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CCBL1—kidney cancer	4.75e-05	0.000268	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—ABCB1—kidney cancer	4.73e-05	0.000267	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—SLC2A1—kidney cancer	4.7e-05	0.000265	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CRABP1—kidney cancer	4.63e-05	0.000261	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—HIF1A—kidney cancer	4.62e-05	0.00026	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—TSC2—kidney cancer	4.61e-05	0.00026	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—GSTM1—kidney cancer	4.59e-05	0.000259	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—POMC—kidney cancer	4.43e-05	0.00025	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—CYP1A1—kidney cancer	4.35e-05	0.000245	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—MYC—kidney cancer	4.33e-05	0.000244	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CDKN1B—kidney cancer	4.31e-05	0.000243	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PSMD7—kidney cancer	4.3e-05	0.000243	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ITPR2—kidney cancer	4.3e-05	0.000243	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—AMER1—kidney cancer	4.3e-05	0.000243	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.25e-05	0.00024	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PDHB—kidney cancer	4.23e-05	0.000239	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CASP2—kidney cancer	4.23e-05	0.000239	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AKAP13—kidney cancer	4.23e-05	0.000239	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—IL2—kidney cancer	4.22e-05	0.000238	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CCND1—kidney cancer	4.11e-05	0.000232	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	4.08e-05	0.00023	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—APC—kidney cancer	4.07e-05	0.000229	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KIT—kidney cancer	4.07e-05	0.000229	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—C-MYB transcription factor network—KRAS—kidney cancer	4e-05	0.000226	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CCBL1—kidney cancer	3.98e-05	0.000225	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GSTP1—kidney cancer	3.92e-05	0.000221	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTT1—kidney cancer	3.92e-05	0.000221	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ACHE—kidney cancer	3.92e-05	0.000221	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—SLC2A1—kidney cancer	3.89e-05	0.00022	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—GRB7—kidney cancer	3.87e-05	0.000218	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—JUNB—kidney cancer	3.86e-05	0.000218	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—BRAF—kidney cancer	3.82e-05	0.000216	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—SCARB1—kidney cancer	3.71e-05	0.000209	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ABCB1—kidney cancer	3.71e-05	0.000209	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS1—kidney cancer	3.67e-05	0.000207	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GSTM1—kidney cancer	3.6e-05	0.000203	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PSMD7—kidney cancer	3.6e-05	0.000203	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—GPC3—kidney cancer	3.6e-05	0.000203	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.6e-05	0.000203	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ITPR2—kidney cancer	3.6e-05	0.000203	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—RAF1—kidney cancer	3.59e-05	0.000203	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PTGS2—kidney cancer	3.54e-05	0.0002	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GLIPR1—kidney cancer	3.45e-05	0.000195	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PPAT—kidney cancer	3.45e-05	0.000195	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CYP1A1—kidney cancer	3.42e-05	0.000193	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—BCHE—kidney cancer	3.42e-05	0.000193	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.41e-05	0.000192	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MAPK3—kidney cancer	3.39e-05	0.000191	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—SLC5A5—kidney cancer	3.37e-05	0.00019	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.37e-05	0.00019	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ST3GAL2—kidney cancer	3.33e-05	0.000188	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MYC—kidney cancer	3.3e-05	0.000186	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CTNNA1—kidney cancer	3.26e-05	0.000184	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—SLC2A1—kidney cancer	3.26e-05	0.000184	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—POMC—kidney cancer	3.24e-05	0.000183	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EIF4EBP1—kidney cancer	3.24e-05	0.000183	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HSPB1—kidney cancer	3.24e-05	0.000183	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	3.23e-05	0.000182	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—IL2—kidney cancer	3.22e-05	0.000182	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—APRT—kidney cancer	3.21e-05	0.000181	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—FH—kidney cancer	3.21e-05	0.000181	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	3.2e-05	0.000181	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—RAF1—kidney cancer	3.19e-05	0.00018	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	3.17e-05	0.000179	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—ERBB2—kidney cancer	3.16e-05	0.000178	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN2B—kidney cancer	3.14e-05	0.000177	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.14e-05	0.000177	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PGK1—kidney cancer	3.12e-05	0.000176	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC5A3—kidney cancer	3.12e-05	0.000176	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MTOR—kidney cancer	3.12e-05	0.000176	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CD4—kidney cancer	3.11e-05	0.000176	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTGS2—kidney cancer	3.09e-05	0.000174	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PTEN—kidney cancer	3.08e-05	0.000174	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—LDHB—kidney cancer	3.06e-05	0.000173	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SFRP2—kidney cancer	3.06e-05	0.000173	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GPC3—kidney cancer	3.02e-05	0.00017	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ANXA1—kidney cancer	3.01e-05	0.00017	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PSMD7—kidney cancer	3.01e-05	0.00017	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TSC1—kidney cancer	3.01e-05	0.00017	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CA2—kidney cancer	2.94e-05	0.000166	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.93e-05	0.000165	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CDKN1B—kidney cancer	2.92e-05	0.000165	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—FLT1—kidney cancer	2.92e-05	0.000165	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALAD—kidney cancer	2.86e-05	0.000161	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TCEB1—kidney cancer	2.86e-05	0.000161	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TCEB2—kidney cancer	2.86e-05	0.000161	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.8e-05	0.000158	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ST3GAL2—kidney cancer	2.79e-05	0.000158	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.79e-05	0.000158	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.77e-05	0.000156	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—CTNNB1—kidney cancer	2.76e-05	0.000156	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—VEGFA—kidney cancer	2.74e-05	0.000154	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ALDH1A1—kidney cancer	2.73e-05	0.000154	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTP1—kidney cancer	2.72e-05	0.000153	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TP53—kidney cancer	2.71e-05	0.000153	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PAK1—kidney cancer	2.71e-05	0.000153	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—JUNB—kidney cancer	2.71e-05	0.000153	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.7e-05	0.000152	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PTEN—kidney cancer	2.69e-05	0.000152	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PGK1—kidney cancer	2.62e-05	0.000148	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC5A3—kidney cancer	2.62e-05	0.000148	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—MAPK3—kidney cancer	2.59e-05	0.000146	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTGS2—kidney cancer	2.59e-05	0.000146	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—ABCB1—kidney cancer	2.57e-05	0.000145	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—LDHB—kidney cancer	2.57e-05	0.000145	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—POMC—kidney cancer	2.55e-05	0.000144	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—HIF1A—kidney cancer	2.51e-05	0.000142	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—TSC2—kidney cancer	2.51e-05	0.000141	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GSTM1—kidney cancer	2.5e-05	0.000141	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—MAPK1—kidney cancer	2.46e-05	0.000139	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.44e-05	0.000138	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CYP1A1—kidney cancer	2.37e-05	0.000134	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—KRAS—kidney cancer	2.33e-05	0.000131	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RPL14—kidney cancer	2.32e-05	0.000131	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.31e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MAPK3—kidney cancer	2.3e-05	0.00013	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PTEN—kidney cancer	2.26e-05	0.000127	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.24e-05	0.000127	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MYC—kidney cancer	2.24e-05	0.000126	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CA9—kidney cancer	2.22e-05	0.000126	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KIT—kidney cancer	2.21e-05	0.000125	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—APC—kidney cancer	2.21e-05	0.000125	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF2—kidney cancer	2.21e-05	0.000125	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN2B—kidney cancer	2.2e-05	0.000124	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.2e-05	0.000124	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—MAPK1—kidney cancer	2.19e-05	0.000124	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—PIK3CA—kidney cancer	2.18e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.17e-05	0.000123	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IGF1R—kidney cancer	2.14e-05	0.000121	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—PIK3CA—kidney cancer	2.14e-05	0.000121	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ITPR2—kidney cancer	2.1e-05	0.000118	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—BRAF—kidney cancer	2.08e-05	0.000117	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.07e-05	0.000117	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—KRAS—kidney cancer	2.07e-05	0.000117	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TP53—kidney cancer	2.07e-05	0.000117	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTGS2—kidney cancer	2.03e-05	0.000115	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.91e-05	0.000107	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PIK3CA—kidney cancer	1.9e-05	0.000107	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CRABP1—kidney cancer	1.89e-05	0.000107	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.84e-05	0.000104	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PTEN—kidney cancer	1.77e-05	0.0001	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—POMC—kidney cancer	1.77e-05	9.96e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—HIF1A—kidney cancer	1.76e-05	9.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PSMD7—kidney cancer	1.76e-05	9.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ITPR2—kidney cancer	1.76e-05	9.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TSC2—kidney cancer	1.76e-05	9.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—RAF1—kidney cancer	1.74e-05	9.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—ERBB2—kidney cancer	1.72e-05	9.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MTOR—kidney cancer	1.7e-05	9.57e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CD4—kidney cancer	1.69e-05	9.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KDR—kidney cancer	1.68e-05	9.5e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTGS2—kidney cancer	1.68e-05	9.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.62e-05	9.15e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ACHE—kidney cancer	1.6e-05	9.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTT1—kidney cancer	1.6e-05	9.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CDKN1B—kidney cancer	1.59e-05	8.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—SLC2A1—kidney cancer	1.59e-05	8.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—PIK3CA—kidney cancer	1.59e-05	8.98e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—JUNB—kidney cancer	1.58e-05	8.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—APC—kidney cancer	1.55e-05	8.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KIT—kidney cancer	1.55e-05	8.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SCARB1—kidney cancer	1.52e-05	8.56e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—CTNNB1—kidney cancer	1.5e-05	8.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PTGS1—kidney cancer	1.5e-05	8.48e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—POMC—kidney cancer	1.48e-05	8.33e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PSMD7—kidney cancer	1.47e-05	8.31e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PTEN—kidney cancer	1.47e-05	8.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—BRAF—kidney cancer	1.46e-05	8.22e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTGS2—kidney cancer	1.41e-05	7.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—BCHE—kidney cancer	1.4e-05	7.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC5A5—kidney cancer	1.38e-05	7.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SLC2A1—kidney cancer	1.33e-05	7.52e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN2B—kidney cancer	1.29e-05	7.26e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAPK3—kidney cancer	1.25e-05	7.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—PIK3CA—kidney cancer	1.25e-05	7.05e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PTEN—kidney cancer	1.23e-05	6.93e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MYC—kidney cancer	1.22e-05	6.88e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RAF1—kidney cancer	1.22e-05	6.87e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RELA—kidney cancer	1.21e-05	6.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ERBB2—kidney cancer	1.2e-05	6.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—MAPK1—kidney cancer	1.19e-05	6.73e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MTOR—kidney cancer	1.19e-05	6.7e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.13e-05	6.36e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—KRAS—kidney cancer	1.13e-05	6.35e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CDKN1B—kidney cancer	1.12e-05	6.29e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTP1—kidney cancer	1.11e-05	6.27e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—IL2—kidney cancer	1.09e-05	6.16e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CCND1—kidney cancer	1.06e-05	6e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—JUN—kidney cancer	1.06e-05	5.99e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CTNNB1—kidney cancer	1.05e-05	5.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ABCB1—kidney cancer	1.05e-05	5.94e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PIK3CA—kidney cancer	1.03e-05	5.84e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—HIF1A—kidney cancer	1.03e-05	5.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PTEN—kidney cancer	1.03e-05	5.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—TSC2—kidney cancer	1.03e-05	5.79e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GSTM1—kidney cancer	1.02e-05	5.76e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CYP1A1—kidney cancer	9.68e-06	5.46e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—VEGFA—kidney cancer	9.27e-06	5.23e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—APC—kidney cancer	9.06e-06	5.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KIT—kidney cancer	9.06e-06	5.11e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK3—kidney cancer	8.77e-06	4.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—PIK3CA—kidney cancer	8.66e-06	4.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MYC—kidney cancer	8.53e-06	4.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—BRAF—kidney cancer	8.51e-06	4.8e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—MAPK1—kidney cancer	8.35e-06	4.71e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.96e-06	4.49e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—KRAS—kidney cancer	7.88e-06	4.45e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PIK3CA—kidney cancer	7.24e-06	4.09e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—POMC—kidney cancer	7.22e-06	4.07e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RAF1—kidney cancer	7.11e-06	4.01e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—ERBB2—kidney cancer	7.03e-06	3.97e-05	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—TP53—kidney cancer	7.01e-06	3.95e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MTOR—kidney cancer	6.94e-06	3.92e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CD4—kidney cancer	6.93e-06	3.91e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CDKN1B—kidney cancer	6.51e-06	3.67e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—CTNNB1—kidney cancer	6.15e-06	3.47e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PTEN—kidney cancer	6e-06	3.38e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAPK3—kidney cancer	5.12e-06	2.89e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PTEN—kidney cancer	5.02e-06	2.83e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MYC—kidney cancer	4.98e-06	2.81e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—MAPK1—kidney cancer	4.88e-06	2.75e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—KRAS—kidney cancer	4.6e-06	2.6e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PIK3CA—kidney cancer	4.23e-06	2.39e-05	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—PIK3CA—kidney cancer	3.54e-06	2e-05	CbGpPWpGaD
